Evolus Inc Stock Ownership - Who owns Evolus?

Insider buying vs selling

Have Evolus Inc insiders been buying or selling?
David N. GillDirector2024-05-146,718$12.60
David N. GillDirector2024-05-133,643$12.73
Vikram MalikDirector2024-05-1328,000$12.93
Rui AvelarChief Medical Officer Head of Research and Development2024-05-103,441$12.72
Sandra BeaverChief Financial Officer2024-05-102,423$12.72
David MoatazediCEO and President2024-05-1016,051$12.72
David MoatazediCEO and President2024-03-276,236$13.86
David MoatazediPresident CEO2024-03-1996,566$13.92
Sandra BeaverChief Financial Officer2024-03-195,672$13.92
Rui AvelarChief Medical Officer Head of Research and Development2024-03-1927,603$13.92

1 of 3

EOLS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EOLS insiders and whales buy or sell their stock.

EOLS Shareholders

What type of owners hold Evolus Inc stock?
Medytox Inc17.00%10,640,826$132.48MInsider
Perceptive Advisors LLC9.19%5,753,798$71.63MInstitution
Alphaeon 1 LLC6.73%4,214,871$52.48MInsider
Tang Capital Management LLC6.62%4,147,399$51.64MInstitution
Blackrock Inc5.21%3,260,786$40.60MInstitution
Morgan Stanley4.86%3,042,803$37.88MInstitution
Nantahala Capital Management LLC4.65%2,910,849$36.24MInstitution
Vanguard Group Inc4.64%2,905,510$36.17MInstitution
Stonepine Capital Management LLC4.27%2,674,356$33.30MInstitution
Great Point Partners LLC3.91%2,450,000$30.50MInstitution

1 of 3

EOLS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EOLS73.48%26.52%Net SellingNet Selling
CGC7.49%92.51%Net Selling
HROW28.65%71.35%Net SellingNet Buying
IRWD72.98%27.02%Net SellingNet Selling

Evolus Stock Ownership FAQ

Who owns Evolus?

Evolus (NASDAQ: EOLS) is owned by 78.84% institutional shareholders, 28.45% Evolus insiders, and 0.00% retail investors. Medytox Inc is the largest individual Evolus shareholder, owning 10.64M shares representing 17.00% of the company. Medytox Inc's Evolus shares are currently valued at $133.12M.

If you're new to stock investing, here's how to buy Evolus stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.